Gensco® Pharma’s abilities provide boundless possibilities for improving health utilizing our unique preparations, innovative dosing methods, and proprietary drug delivery technologies.
Transdermal Technology Gensco® Pharma has developed and patented a unique transdermal drug delivery system... read more
MDose® Gensco® Pharma’s patented topical metered dose applicator dispenses an exact and consistent dose of medication with every pump... read more
LidoDose® The Single Dose™ Topical Anesthetic & Antiseptic for Preprocedural Use... read more
ColciGel® Prepare for the flare with the first transdermal treatment for gout flares... read more
Astero® The first FDA-approved prescription combination drug-device hydrogel containing Lidocaine 4% HCl for associated pain, wound healing and vasculitis.... read more
LiDORx® Delivers fast controlled pain relief at the site... read more
SpeedGel Rx® Non-NSAID alternative for pain, inflammation and bruising. Targeting the source of pain... faster... read more
- January 24 - January 26
- February 21 - February 23
- February 27 - February 28
- March 6 - March 9
- March 7 - March 10
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To more...
- A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management November 13, 2017 Articles, Clinical, Featured, Research -
- An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research -